Salīdzināt metodes

	MSFC: Multiplās sklerozes funkcionālais kompozīts	RMI: Rivermead Mobility Index
Nozare	Neiroloģija	Neiroloģija
Saime	Process / pipeline	Process / pipeline
Izcelsmes gads	1999	1991
Autors	Gary Cutter, Richard Rudick, and NMSS Consortium	Frank Collen, Derick Wade, and Rivermead Rehabilitation Centre
Tips	Clinician-administered performance test	Clinician-observed performance test
Pirmavots	Cutter, G. R., Baier, M. L., Rudick, R. A., et al. (1999). Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Multiple Sclerosis, 5(4), 244-250.	Collen, F. M., Wade, D. T., Robb, G. F., Bradshaw, C. M. (1991). The Rivermead Mobility Index: A further development of the Rivermead Motor Assessment. International Disability Studies, 13(2), 50-54.
Citi nosaukumi	MS Functional Composite	Rivermead Mobility Index
Saistītās	4	5
Kopsavilkums	The Multiple Sclerosis Functional Composite (MSFC) is an objective, performance-based assessment of MS-related disability capturing three key functional domains: lower extremity mobility, upper extremity coordination, and cognitive/processing speed. Developed in 1999 by the National MS Society and adopted widely in clinical trials, the MSFC provides quantifiable endpoints complementing the Expanded Disability Status Scale (EDSS). The three-component design addresses EDSS limitations by including cognition and standardizing measurement via timed tasks.	The Rivermead Mobility Index (RMI) is a brief, clinician-observed performance test of basic mobility abilities developed for assessing stroke and neurological rehabilitation outcomes. Published in 1991 by Frank Collen and colleagues at Rivermead Rehabilitation Centre (Oxford, UK), the 15-item index measures bed mobility, sitting/standing balance, transfers, and ambulation. The RMI is widely used in stroke units and rehabilitation settings to track functional recovery and predict discharge outcomes.